57469-77-9Ibuprofen Lysine

Ibuprofen Lysine, also known as Ibuprofen lysinate; Neoprofen; Arflamin; Solufenum; Soluphene; Saren; Lisiprofen; Imbun; Dolormin; ibuprofen l-lysine; p-Isobutylphenyl-2-propionate lysine; L-Lysine mono(4-isobutyl-alpha-methylbenzeneacetate); (2S)-2,6-diaminohexanoic acid;2-[4-(2-methylpropyl)phenyl]propanoic acid; L-lysine compound with 2-(4-isobutylphenyl)propanoic acid (1:1); [(5S)-5-amino-5-carboxypentyl]azanium;2-[4-(2-methylpropyl)phenyl]propanoate, is a highly characterized reference material. It fully complies with stringent regulatory standards, including those set by USP, EMA, JP, and BP. This product is essential for use in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial production of Ibuprofen. Moreover, it comes with a detailed Structure Elucidation Report (SER), ensuring its accuracy and reliability for a wide range of analytical applications. It is an impurity present in Ibuprofen, Ibuprofen is a non-selective COX inhibitor, ibuprofen is considered an NSAID and thus it is a non-selective inhibitor of cyclooxygenase, which is an enzyme involved in prostaglandin and thromboxane synthesis via the arachidonic acid pathway. which inhibits the activity of both COX-1 and COX-2, inhibition of COX-2 activity decreases the synthesis of prostaglandins involved in mediating inflammation, pain, fever, and swelling while the inhibition of COX-1